Purchase Order 15B41226P00000192

<p>Federal Medical Center Rochester awarded a purchase order to Pantherx Specialty, LLC for $60,000.00 on August 1, 2026, for Crenessity medication. Performance is at Pittsburgh, Pennsylvania, with an ultimate completion date of August 31, 2026. The order is firm fixed price with no small business set-aside.</p>

<p>Federal Medical Center Rochester issued a purchase order to Pantherx Specialty, LLC, valued at $58,926.80 on July 1, 2026, for Crenessity medication. This modification represents a decrease of $1,073.20 from the prior order value. Performance is located in Pittsburgh, Pennsylvania, with an ultimate completion date of July 31, 2026. The order is firm fixed price with no small business set-aside.</p>

The Federal Medical Center Rochester, a unit of the Department of Justice Bureau of Prisons, awarded a purchase order to Pantherx Specialty, LLC for $58,926.80 on May 1, 2026. The order, designated Modification 1 (a funding action reducing the contract by $1,073.20), carries a ceiling value of $58,926.80 and firm fixed-price terms with an ultimate completion date of May 31, 2026. Performance occurs in Pittsburgh, Pennsylvania. The order is part of the B1 PANTHERX CRENESSITY pharmaceutical supply...

The U.S. Department of Justice Bureau of Prisons' Federal Medical Center Rochester awarded a $39,284.60 firm fixed-price purchase order to Pantherx Specialty, LLC on April 1, 2026, with an ultimate completion date of April 30, 2026. The contract, designated B1 - PANTHERX - CRENESSITY, does not utilize a small business set-aside. Pantherx Specialty, LLC, which operates as Pantherx Specialty Pharmacy and is headquartered in Pittsburgh, Pennsylvania, will perform work at its Pittsburgh, PA...

The Federal Medical Center Rochester, operated by the Department of Justice Bureau of Prisons, awarded a firm fixed-price purchase order valued at $39,284.60 to Pantherx Specialty, LLC on February 1, 2026, with an ultimate completion date of February 28, 2026. The contract, designated as &quot;B1 - PANTHERX - MEDICATION FEB 26,&quot; does not utilize a small business set-aside. Pantherx Specialty, a Pittsburgh, Pennsylvania-based specialty pharmacy and subsidiary of Centene Corporation, will...

The Department of Justice Bureau of Prisons Federal Medical Center Rochester awarded a $43,869.35 firm fixed price purchase order to Pantherx Specialty LLC, doing business as Pantherx Specialty Pharmacy and a subsidiary of Centene Corporation, for pharmacy services. The order is for Pantherx to provide pharmaceutical products and services to inmates at the Federal Medical Center Rochester facility in Pittsburgh, Pennsylvania from July 31, 2023 through August 4, 2023. As the Bureau of Prisons...

The Federal Medical Center Rochester, operated by the Department of Justice Bureau of Prisons, awarded a modification to Pantherx Specialty, LLC, a specialty pharmacy headquartered in Pittsburgh, Pennsylvania, resulting in a decrease of $1,144.22 to the contract ceiling value, which now stands at $38,140.38. This firm fixed-price purchase order, issued on January 1, 2026, with an ultimate completion date of January 31, 2026, does not utilize a small business set-aside designation. Pantherx...

<p>Federal Medical Center Rochester awarded a purchase order to McKesson Corporation on February 1, 2026, with a ceiling value of $7,614.61 for pharmaceutical and medical supplies. The modification reflects a decrease of $5,385.39 from a prior obligation. Place of performance is Irving, Texas. The order carries firm fixed pricing with an ultimate completion date of February 28, 2026. No small business set-aside applies.</p>

<p>The Federal Medical Center Rochester issued a purchase order to McKesson Corporation on February 1, 2026, with a ceiling value of $1,350.07 for controlled medications. The order is firm fixed price with an ultimate completion date of February 28, 2026. Performance occurs in Irving, Texas. No set-aside was used. This represents a modification (MOD 2) that decreased the order value by $2,299.86 from an earlier funded amount.</p>

<p>Federal Medical Center Rochester awarded a purchase order to McKesson Corporation on March 1, 2026, with a firm fixed price ceiling of $2,852.39. This modification represents a decrease of $2,147.61 from the prior order value. The purchase order is for controlled medications and pharmaceutical supplies, with performance through March 31, 2026, and place of performance in Irving, Texas. No small business set-aside applies.</p>